Articles related to VACCINES/IMMUNIZATION

The updated COVID-19 vaccines generate a more pronounced and specific immune response against current circulating strains, potentially reducing infection rates and, crucially, severe disease.

The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.

The study found that while PASC risk has decreased over time, it remains a significant concern even among vaccinated individuals infected during the omicron era.

The 2022 ACIP recommendations introduce new pneumococcal conjugate vaccines and simplified dosing schedules, aiming to enhance prevention of invasive pneumococcal disease while improving guideline implementation in clinical practice.

Immunocompromised individuals are at a 6 to 11 times higher risk of developing herpes zoster compared to the general population, with hematopoietic stem cell transplant recipients facing the highest risk.